Identification of ras/raf binding site and design of interfering peptide with potential clinical application (original) (raw)

T cell leukemia control via Ras-Raf pathway inhibition with peptides

Gustavo Horacio Marin

Journal of medicine and life

View PDFchevron_right

In-silico design of peptide inhibitors of K-Ras target in cancer disease

Masaud Shah

Journal of Biomolecular Structure and Dynamics, 2019

View PDFchevron_right

Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors

hourieh kalhor

PLOS Computational Biology

View PDFchevron_right

Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes

Channing Der

Journal of Biological Chemistry, 1995

View PDFchevron_right

Targeting Ras with Macromolecules

Dehua Pei

Cold Spring Harbor Perspectives in Medicine, 2017

View PDFchevron_right

Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells

Elena Sacco

Biotechnology Advances, 2012

View PDFchevron_right

New druggable targets in the Ras pathway?

David Matallanas

Current opinion in molecular therapeutics, 2010

View PDFchevron_right

Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells

Ilya Serebriiskii

Proceedings of the National Academy of Sciences of the United States of America, 2002

View PDFchevron_right

Direct Ras inhibitors identified from a structurally rigidified bicyclic peptide library

Dehua Pei

Tetrahedron, 2014

View PDFchevron_right

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy

Yaohe Wang

Frontiers in Immunology

View PDFchevron_right

Engineering protein-specific proteases: targeting active RAS

Biao Ruan

2020

View PDFchevron_right

Drugging the Undruggable: Advances on RAS Targeting in Cancer

Julian Downward

Genes, 2021

View PDFchevron_right

Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides

Dehua Pei

ACS combinatorial science, 2016

View PDFchevron_right

Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP

Kathleen Prinzo

Journal of Biological Chemistry, 1994

View PDFchevron_right

Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function

Sharon Campbell

Proceedings of the National Academy of Sciences, 1996

View PDFchevron_right

Inhibition of Ras Signaling by Blocking Ras-Effector Interactions with Cyclic Peptides

Dehua Pei

Angewandte Chemie, 2015

View PDFchevron_right

Inhibitors of RAS signal transduction as antitumor agents

Christiane Garbay

Biochemical Pharmacology, 2000

View PDFchevron_right

Ras oncoprotein inhibitors: The discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex

D. Delisle

Bioorganic & Medicinal Chemistry, 1997

View PDFchevron_right

Significance of Ras Signaling in Cancer and Strategies for its Control

Arun B Gurung

Oncology & Hematology Review (US), 2015

View PDFchevron_right

Ras family signaling: therapeutic targeting

Adrienne Cox

Cancer biology & therapy

View PDFchevron_right

Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1

Jens Sydor, Martin Engelhard

Proceedings of the National Academy of Sciences, 1999

View PDFchevron_right

Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling

Angel Gonzalez

Chemistry - A European Journal, 2017

View PDFchevron_right

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Kaushik Dutta

Cell, 2016

View PDFchevron_right

Targeting RAS signalling pathways in cancer therapy

Julian Downward

Nature Reviews Cancer, 2003

View PDFchevron_right

Improved Binding of Raf to Ras·GDP Is Correlated with Biological Activity

Hans Kalbitzer

Journal of Biological Chemistry, 2009

View PDFchevron_right

Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D

Alessandro Palmioli

Biochemical and Biophysical Research Communications, 2009

View PDFchevron_right

Eliminating oncogenic RAS: back to the future at the drawing board

Pelin Kaya

Biochemical Society Transactions, 2023

View PDFchevron_right

Computational Design of Myristoylated Cell Penetrating Peptides Targeting Oncogenic K-Ras.G12D at the Effector Binding Membrane Interface

Matthias Buck

2019

View PDFchevron_right